Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TEDUGLUTIDE for Intestinal obstruction: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where TEDUGLUTIDE was used for Intestinal obstruction.

Most Reported Side Effects for TEDUGLUTIDE

Side Effect Reports % Deaths Hosp.
Vascular device infection 1,009 11.5% 42 941
Weight decreased 991 11.3% 83 742
Product dose omission issue 937 10.7% 65 728
Diarrhoea 779 8.9% 57 548
Abdominal pain 714 8.1% 40 510
Nausea 682 7.8% 45 463
Weight increased 631 7.2% 45 462
Dehydration 615 7.0% 56 520
Vomiting 585 6.7% 38 430
Death 527 6.0% 527 214
Abdominal distension 515 5.9% 27 338
Pyrexia 479 5.5% 27 430
Hospitalisation 453 5.2% 29 453
Decreased appetite 438 5.0% 32 316
Inappropriate schedule of product administration 433 4.9% 47 303

Other Indications for TEDUGLUTIDE

Short-bowel syndrome (7,627) Product used for unknown indication (970) Malabsorption (200) Crohn's disease (199) Functional gastrointestinal disorder (69) Gastrointestinal disorder (34) Illness (31) Malnutrition (28) Diarrhoea (25) Intestinal fistula (18)

Other Drugs Used for Intestinal obstruction

POLYETHYLENE GLYCOL 3350 (120) OCTREOTIDE (53) LINACLOTIDE (34) ADALIMUMAB (17) RANITIDINE (13) POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM (10) PREDNISONE (10) DEXAMETHASONE (9) USTEKINUMAB (9) BUTYLSCOPOLAMINE (8)

Related Pages

TEDUGLUTIDE Full Profile All Intestinal obstruction Drugs TEDUGLUTIDE Demographics TEDUGLUTIDE Timeline